EPPIC researchers present in first MOHCCN Seminar Series
Researchers from TFRI's Enhanced Pancreatic Cancer Profiling for Individualized Care presented during the first event of the Marathon of Hope Cancer Centres Network Seminar Series.
The event included a keynote address by Dr. Daniel Renouf, and presentations from Dr. Yifan Wang, and Drs. James Topham and Erica Tsang. Dr. George Zogopoulos moderated the event.
Below you can see a video of the entire presentation.
The event included a keynote address by Dr. Daniel Renouf, and presentations from Dr. Yifan Wang, and Drs. James Topham and Erica Tsang. Dr. George Zogopoulos moderated the event.
Related Team Member
-
Daniel
MOHCCN Steering CommitteeConsortium LeaderWorking Group Member
Renouf
-
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
Related News
-
Leadership and researchers at the Princess Margaret Cancer Consortium present updates to Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
Study Reveals Cause for Different Outcomes for Patients that Experience Early and Late Relapse of Diffuse Large B-cell Lymphoma
A recent study by MOHCCN-funded researchers at BC Cancer is helping to accelerate precision medicine for cancer by shedding new light on why some patients with relapsed DLBCL respond well to standard-... -
MOHCCN Pathfinder Project clears the way for future data sharing between Network members
Through its Pathfinder Project, the MOHCCN has developed and deployed a technical tool that allows members to upload, discover – and eventually access – the data needed to accelerate precision medicin... -
New study finds that location of immune cells is critical for immunotherapy response
An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a patients’ response to immune therapy.